NEOG Stock Analysis: Buy, Sell, or Hold?

NEOG - Neogen Corp

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$9.34
0.03 (0.32%) ▲
5d: -1.79%
30d: +6.74%
90d: -0.53%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026 30d
Smart Money Distribution

None View Scanner →

Strength: 7.7/10

Get Alerted When NEOG Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: NEOG shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$5.00
Based on -7.4% avg growth
INTRINSIC VALUE TODAY
$3.10
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: NEOG is currently trading at $9.34, which is considered slightly high relative to its 30-day fair value range of $8.92 to $9.33. The stock's valuation (Forward PE: 31.1) is in line with its historical norms (28.6). At these levels, the market is pricing in 2.9% annual earnings growth.

Technical Outlook: Technically, NEOG is in a strong downtrend. Immediate support is located at $8.69, while resistance sits at $9.68.

Market Sentiment: NEOG has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+28.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $8.92 - $9.33
Company Quality Score 62/100 (BUY)
Volume Confirmation HIGH
Confidence Score 79.5%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 28.5% below Wall St target ($12.00)
  • BULLISH: Expecting earnings turnaround to 2.9% growth with -4.4% revenue growth

Trading Range Analysis

30-Day Trading Range $8.92 - $9.33
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $8.69
Resistance Level $9.68
Current Trend Strong Downtrend
Technical data as of Jul 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) 31.13
Wall Street Target $12.00 (+28.5%)
Revenue Growth (YoY) -4.4%
Earnings Growth (YoY) -85.6%
Profit Margin -69.9%
Valuation Premium vs History +2.9% premium
PE vs Historical 31.1 vs 28.6 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.9% (market-implied from PE analysis)
1-Year Target $9.61 (+3%)
2-Year Target $9.89 (+6%)
3-Year Target $10.18 (+9%)
3-Yr Target (if PE normalizes) (PE: 31→29) PE COMPRESSION $9.35 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 31.1, Growth: -18.9%) $6.81 (+-27%)
Base: (SPY PE: 21.8, Growth: -18.9%) $4.76 (-49%)
Bear: (PE: 18.5, Growth: -18.9%) $4.05 (-57%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 03, 2026 7:03 PM ET
Data refreshes hourly during market hours. Next update: 8:03 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Mikheal Nassif BUY 23 shares 2026-02-17
Mikheal Nassif BUY 24 shares 2026-02-02
Mikheal Nassif BUY 25 shares 2026-01-26

Unlock Insider Activity

See real-time buying/selling by company executives for NEOG.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$75 65 BUY
DXCM
DexCom Inc
STRONG BUY
27 analysts
$85 58 HOLD
ABT
Abbott Laboratories
STRONG BUY
27 analysts
$117 65 BUY
PODD
Insulet Corporation
STRONG BUY
24 analysts
$240 65 BUY
MDT
Medtronic PLC
BUY
32 analysts
$98 65 BUY

Advanced NEOG Option Strategies

Professional options setups generated by AI based on today's NEOG price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NEOG

NEOG Technical Chart NEOG Price Prediction NEOG Earnings Date NEOG Investment Advisor NEOG Fair Price Analyzer NEOG Options Advisor NEOG Options Chain NEOG Options Analysis NEOG Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals